StonvexLoading…
StonvexStonvexStonvexCore line items from GENK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $58.34M | $53.90M | $212.54M | $162.79M | $112.38M |
Operating Income | Not available | $-7.21M | $-19.99M | $-7.80M | $-4.06M |
Net Income | Not available | $-1.17M | $-3.03M | $-1.13M | $-562.00K |
EPS (Diluted) | $-0.06 | $-0.22 | $-0.59 | $-0.22 | $-0.11 |
Total Assets | Not available | $259.08M | $259.86M | $245.54M | $246.33M |
Total Liabilities | Not available | $237.67M | $231.85M | $205.95M | $203.80M |
Cash & Equivalents | Not available | $4.43M | $2.82M | $4.79M | $9.61M |
Free Cash Flow OCF − CapEx | Not available | $-667.00K | $-24.32M | $-18.68M | $-10.99M |
Shares Outstanding | Not available | 5.33M | 5.16M | 5.13M | 5.07M |